Uracil

Uracil

SCHEMBL21385227

O=c1cc[nH]c(=O)[nH]1.P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uracil SCHEMBL8235 0.97
Uracil SCHEMBL3798527 0.97 CRBN (1.00)
Uracil SCHEMBL5089507 0.97
Uracil SCHEMBL6703252 0.94
Uracil SCHEMBL11130705 0.94
Uracil SCHEMBL16116311 0.94
Uracil SCHEMBL710130 0.94
Uracil SCHEMBL156275 0.94
Uracil SCHEMBL18010636 0.94
Uracil SCHEMBL2557975 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182422-A1 NOVEL GENETICALLY MODIFIED NATURAL KILLER CELL LINE AND USE THEREOF 주식회사 에스엘바이젠 2019-09-26 WO claimed
CN-110520540-A Nucleic acid modification and identification methods IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBH 2019-11-29 CN disclosed
CN-110408580-A The method for producing the recombinant microorganism of cytimidine and producing cytimidine SUZHOU BIOSYNTHETICA INC 2019-11-05 CN disclosed